GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 355,509 | $17,171,000 | 9.58% |
| Perceptive Advisors | 4,989,066 | $240,971,000 | 6.75% |
| GREAT POINT PARTNERS LLC | 736,631 | $35,579,000,000 | 5.28% |
| Casdin Capital, LLC | 600,000 | $28,980,000 | 5.10% |
| Avoro Capital Advisors LLC | 1,765,548 | $85,276,000 | 4.07% |
| Iguana Healthcare Management, LLC | 115,000 | $5,555,000 | 3.65% |
| Camber Capital Management LP | 1,200,000 | $57,960,000 | 2.85% |
| NEXTHERA CAPITAL LP | 315,147 | $15,222,000 | 2.51% |
| RTW INVESTMENTS, LP | 456,921 | $22,069,000 | 2.10% |
| EMORY UNIVERSITY | 41,610 | $2,010,000 | 1.44% |